Dobutamine

  • Description and indication for use

    Dobutamine is a synthetic catecholamine (cardiac inotrope). It preferentially dilates the coronary beds and does not cause vasodilation in renal and mesenteric areas.  Dobutamine has less tendency to cause arrythmias and less of a hypertensive effect than dopamine.  It is used to increase myocardial contractility and cardiac output.

    Dose

    IV infusion:        

    2.5 to 20 mcg/kg/minute starting at 5 micrograms/kg/min.

    Reconstitution/Dilution

    Vial = 250 mg in 20 mL solution (12.5 mg/mL).

    Withdraw ordered dose and make up to ordered infusion volume.

    Usual order will be as follows:

    Drug How to make up Dose equivalent Dose range
    Dobutamine 60 mg/kg  in 50 mL glucose 10% 1 mL/hr = 20 micrograms/kg/min 4 - 20 micrograms/kg/min

    Can also be made up with glucose 5% solution.

    Route and method of administration

    Not for IV bolus or IM use.

    IV Infusion:        

    Continuous IV infusion using a syringe pump (preferably via a central line, but may be given peripherally if central access is non-existent).

    Side effects

    May cause hypotension if patient hypovolemic.

    Tachycardia.

    Arrythmias.

    TISSUE ISCHAEMIA occurs with infiltration.

    Hypertension.

    Cutaneous Vasodilation.

    Incompatibilities

    Sodium bicarbonate and phenytoin.

    Aminophylline.

    Calcium gluconate (treatment concentrations).

    Diazepam.

    Frusemide.

    Digoxin.

    Special precautions

    Caution in patients with hypertension.

    Hypovolaemia should be corrected before dobutamine administration.

    Do not bolus other drugs via dobutamine infusion.

    Solution may exhibit a pink color with no significant loss of potency over 24 hours.

    Nursing responsibilities

    Carefully prime IV tubing.

    USE SYRINGE PUMP.

    Continuous blood pressure monitoring preferably with an arterial line.

    Continuously monitor heart rate and rhythm.

    Record vital signs hourly.

    Observe and measure urine output.

    Observe IV site for inflammation and extravasation of fluid, remove immediately if occurs.

    Avoid interruption of infusion.

    DO NOT ADMINISTER ANY BOLUS DOSES.

    Change infusion fluid every 24 hours and tubing every 3 days (as per RCH IV Line Protocol) ensuring that the 3-way tap is turned off during syringe change to prevent any inadvertent bolus dose being given.

    Check that rate ordered corresponds with dose required (micrograms/kg/min).

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for